학술논문
Translation and cross-cultural adaptation to Brazilian Portuguese of two brief screening tools for at-risk psychosis youth: the Prodromal Questionnaire (PQ-16) and the PRIME-Screen.
Document Type
Academic Journal
Author
Aguiar AP; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Instituto #amesuamente.; Vistorte AOR; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Instituto #amesuamente.; Akiba HT; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Instituto #amesuamente.; Oliveira P; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Instituto #amesuamente.; Ruiz DPP; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Instituto #amesuamente.; Gadelha A; Instituto Ame Sua Mente, São Paulo, SP, Brazil. Programa de Esquizofrenia da Unifesp (PROESQ).; Bressan RA; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Instituto #amesuamente.; Pan PM; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Instituto #amesuamente.
Source
Publisher: Associação de Psiquiatria do Rio Grande do Sul Country of Publication: Brazil NLM ID: 101610695 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2238-0019 (Electronic) Linking ISSN: 22376089 NLM ISO Abbreviation: Trends Psychiatry Psychother Subsets: MEDLINE
Subject
Language
English
Abstract
Introduction: Prodromal characteristics of psychosis have been described for more than a century. Over the last three decades, a variety of studies have proposed methods to prospectively identify individuals (and youth in particular) who are at high risk of developing a psychotic disorder. These studies have validated various screening instruments and made them available in several languages. Here, we describe the translation into Brazilian Portuguese and cross-cultural adaptation of two such screening tools - the Prodromal Questionnaire-16 (PQ-16) and the Prevention through Risk Identification, Management, and Education (PRIME)-Screen.
Method: Two bilingual native speakers of Brazilian Portuguese translated the questionnaires from English. A native English speaker then performed back-translations into English. These back-translated versions were submitted to the original authors. They provided feedback and later approved the final versions.
Results: After translation and cross-cultural adaptation, no items needed to be changed in the adapted PQ-16 and four items were revised in the PRIME-Screen. After the peer-review process, we included two suggestions in the PQ-16 to facilitate use of the tool in our cultural and social contexts. The PRIME-Screen did not need further changes.
Conclusion: These new instruments can help screen Brazilian Portuguese-speaking patients who are at risk of psychosis in primary care.
Competing Interests: Ary Gadelha has been a consultant and/or advisor to or has received honoraria from Aché, Daiichi-Sankyo, Torrent, Bayer, Cristalia, and Janssen. Rodrigo Affonseca Bressan has received research grants from Eli-Lilly, Lundbeck, Novartis, Roche, and Janssen; has been a shareholder in Biomolecular Technology Ltd.; and has received speaking fees from AstraZeneca, Bristol, EliLilly, Lundbeck, Janssen, Aché, and Torrent. Pedro Mario Pan has received personal fees from Sandoz, Daiichi Sankyo, Eurofarma, and Abbott. No other conflicts of interest are declared concerning publication of this article.
Method: Two bilingual native speakers of Brazilian Portuguese translated the questionnaires from English. A native English speaker then performed back-translations into English. These back-translated versions were submitted to the original authors. They provided feedback and later approved the final versions.
Results: After translation and cross-cultural adaptation, no items needed to be changed in the adapted PQ-16 and four items were revised in the PRIME-Screen. After the peer-review process, we included two suggestions in the PQ-16 to facilitate use of the tool in our cultural and social contexts. The PRIME-Screen did not need further changes.
Conclusion: These new instruments can help screen Brazilian Portuguese-speaking patients who are at risk of psychosis in primary care.
Competing Interests: Ary Gadelha has been a consultant and/or advisor to or has received honoraria from Aché, Daiichi-Sankyo, Torrent, Bayer, Cristalia, and Janssen. Rodrigo Affonseca Bressan has received research grants from Eli-Lilly, Lundbeck, Novartis, Roche, and Janssen; has been a shareholder in Biomolecular Technology Ltd.; and has received speaking fees from AstraZeneca, Bristol, EliLilly, Lundbeck, Janssen, Aché, and Torrent. Pedro Mario Pan has received personal fees from Sandoz, Daiichi Sankyo, Eurofarma, and Abbott. No other conflicts of interest are declared concerning publication of this article.